141 related articles for article (PubMed ID: 20443680)
1. Leptin receptor expression and its association with PI3K/AKT signaling pathway in diffuse large B-cell lymphoma.
Uddin S; Bu R; Ahmed M; Hussain AR; Ajarim D; Al-Dayel F; Bavi P; Al-kuraya KS
Leuk Lymphoma; 2010 Jul; 51(7):1305-14. PubMed ID: 20443680
[TBL] [Abstract][Full Text] [Related]
2. Leptin-R and its association with PI3K/AKT signaling pathway in papillary thyroid carcinoma.
Uddin S; Bavi P; Siraj AK; Ahmed M; Al-Rasheed M; Hussain AR; Ahmed M; Amin T; Alzahrani A; Al-Dayel F; Abubaker J; Bu R; Al-Kuraya KS
Endocr Relat Cancer; 2010 Mar; 17(1):191-202. PubMed ID: 20008098
[TBL] [Abstract][Full Text] [Related]
3. Leptin receptor expression in Middle Eastern colorectal cancer and its potential clinical implication.
Uddin S; Bavi PP; Hussain AR; Alsbeih G; Al-Sanea N; Abduljabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Ahmed M; Al-Kuraya KS
Carcinogenesis; 2009 Nov; 30(11):1832-40. PubMed ID: 19520793
[TBL] [Abstract][Full Text] [Related]
4. Role of phosphatidylinositol 3'-kinase/AKT pathway in diffuse large B-cell lymphoma survival.
Uddin S; Hussain AR; Siraj AK; Manogaran PS; Al-Jomah NA; Moorji A; Atizado V; Al-Dayel F; Belgaumi A; El-Solh H; Ezzat A; Bavi P; Al-Kuraya KS
Blood; 2006 Dec; 108(13):4178-86. PubMed ID: 16946303
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-21 plays an oncogenic role by targeting FOXO1 and activating the PI3K/AKT pathway in diffuse large B-cell lymphoma.
Go H; Jang JY; Kim PJ; Kim YG; Nam SJ; Paik JH; Kim TM; Heo DS; Kim CW; Jeon YK
Oncotarget; 2015 Jun; 6(17):15035-49. PubMed ID: 25909227
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of leptin receptor predicts an unfavorable outcome in Middle Eastern ovarian cancer.
Uddin S; Bu R; Ahmed M; Abubaker J; Al-Dayel F; Bavi P; Al-Kuraya KS
Mol Cancer; 2009 Sep; 8():74. PubMed ID: 19765303
[TBL] [Abstract][Full Text] [Related]
7. Expression and significance of leptin receptor, p-STAT3 and p-AKT in diffuse large B-cell lymphoma.
Lin S; YuJun L; XiaoMing X; WenWen R
Acta Histochem; 2014 Jan; 116(1):126-30. PubMed ID: 24054064
[TBL] [Abstract][Full Text] [Related]
8. Activation of the PI3K/AKT/mTOR pathway in diffuse large B cell lymphoma: clinical significance and inhibitory effect of rituximab.
Xu ZZ; Xia ZG; Wang AH; Wang WF; Liu ZY; Chen LY; Li JM
Ann Hematol; 2013 Oct; 92(10):1351-8. PubMed ID: 23636313
[TBL] [Abstract][Full Text] [Related]
9. Leptin exerts proliferative and anti-apoptotic effects on goose granulosa cells through the PI3K/Akt/mTOR signaling pathway.
Wen R; Hu S; Xiao Q; Han C; Gan C; Gou H; Liu H; Li L; Xu H; He H; Wang J
J Steroid Biochem Mol Biol; 2015 May; 149():70-9. PubMed ID: 25576904
[TBL] [Abstract][Full Text] [Related]
10. Phospho-p70S6K/p85S6K and cdc2/cdk1 are novel targets for diffuse large B-cell lymphoma combination therapy.
Zhao MY; Auerbach A; D'Costa AM; Rapoport AP; Burger AM; Sausville EA; Stass SA; Jiang F; Sands AM; Aguilera N; Zhao XF
Clin Cancer Res; 2009 Mar; 15(5):1708-20. PubMed ID: 19223503
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of AKT phosphorylation and PTEN loss and their correlation with the resistance of rituximab in DLBCL.
Ma Y; Zhang P; Gao Y; Fan H; Zhang M; Wu J
Int J Clin Exp Pathol; 2015; 8(11):14875-84. PubMed ID: 26823817
[TBL] [Abstract][Full Text] [Related]
12. SPIB is a novel prognostic factor in diffuse large B-cell lymphoma that mediates apoptosis via the PI3K-AKT pathway.
Takagi Y; Shimada K; Shimada S; Sakamoto A; Naoe T; Nakamura S; Hayakawa F; Tomita A; Kiyoi H
Cancer Sci; 2016 Sep; 107(9):1270-80. PubMed ID: 27348272
[TBL] [Abstract][Full Text] [Related]
13. Leptin induces functional activation of cyclooxygenase-2 through JAK2/STAT3, MAPK/ERK, and PI3K/AKT pathways in human endometrial cancer cells.
Gao J; Tian J; Lv Y; Shi F; Kong F; Shi H; Zhao L
Cancer Sci; 2009 Mar; 100(3):389-95. PubMed ID: 19154413
[TBL] [Abstract][Full Text] [Related]
14. [Effects of AKT protein kinase activation on biologic behavior of diffuse large B cell lymphoma cells].
Zhang TC; Zhou XY; Yu BH; Zhang TM; Shi DR
Zhonghua Bing Li Xue Za Zhi; 2007 May; 36(5):318-23. PubMed ID: 17706139
[TBL] [Abstract][Full Text] [Related]
15. Adipocytes contribute to resistance of human melanoma cells to chemotherapy and targeted therapy.
Chi M; Chen J; Ye Y; Tseng HY; Lai F; Tay KH; Jin L; Guo ST; Jiang CC; Zhang XD
Curr Med Chem; 2014 Apr; 21(10):1255-67. PubMed ID: 24304284
[TBL] [Abstract][Full Text] [Related]
16. Annexin A5 inhibits diffuse large B-cell lymphoma cell invasion and chemoresistance through phosphatidylinositol 3-kinase signaling.
Wang J; Zhang Y; Liu X; Ma J; Liu P; Hu C; Zhang G
Oncol Rep; 2014 Dec; 32(6):2557-63. PubMed ID: 25323007
[TBL] [Abstract][Full Text] [Related]
17. TCL1 as a hub protein associated with the PI3K/AKT signaling pathway in diffuse large B-cell lymphoma based on proteomics methods.
Gao HX; Li SJ; Niu J; Ma ZP; Nuerlan A; Xue J; Wang MB; Cui WL; Abulajiang G; Sang W; Zhang W; Li XX
Pathol Res Pract; 2020 Feb; 216(2):152799. PubMed ID: 31932115
[TBL] [Abstract][Full Text] [Related]
18. Activation of mammalian target of rapamycin signaling pathway contributes to tumor cell survival in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma.
Vega F; Medeiros LJ; Leventaki V; Atwell C; Cho-Vega JH; Tian L; Claret FX; Rassidakis GZ
Cancer Res; 2006 Jul; 66(13):6589-97. PubMed ID: 16818631
[TBL] [Abstract][Full Text] [Related]
19. Leptin regulates proliferation and apoptosis of colorectal carcinoma through PI3K/Akt/mTOR signalling pathway.
Wang D; Chen J; Chen H; Duan Z; Xu Q; Wei M; Wang L; Zhong M
J Biosci; 2012 Mar; 37(1):91-101. PubMed ID: 22357207
[TBL] [Abstract][Full Text] [Related]
20. Sirt6 promotes tumorigenesis and drug resistance of diffuse large B-cell lymphoma by mediating PI3K/Akt signaling.
Yang J; Li Y; Zhang Y; Fang X; Chen N; Zhou X; Wang X
J Exp Clin Cancer Res; 2020 Jul; 39(1):142. PubMed ID: 32711549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
